By joining New Jersey’s largest insurance companies with researchers, cancer patients, healthcare professionals, and pharmaceutical industry representatives through a consensus agreement, New Jersey cancer patients now have insurance coverage for the routine healthcare costs of phase I, II, and III approved cancer clinical trials. The NJ Working Group to Improve Outcomes in Cancer Patients was created to oversee the agreement and find innovative ways to help patients enroll in treatment and prevention trials.